Organ-on-chip & MPSreported
MEPSGEN
Seoul-based developer of MEPS-X human microphysiological systems for toxicity and efficacy testing; also sells lipid nanoparticle manufacturing systems.
Related deals
- Nov 19, 2024Venture financing, Series CSeries C for an organ-on-chip developer, per Tracxn.
Related updates
No related news yet.